Practice
Featured experience
Bristol Myers Squibb €5 billion notes offering
We advised the underwriters on Bristol Myers Squibb Ireland’s inaugural euro issuance
BETA Technologies $1 billion IPO
The shares are listed on the New York Stock Exchange
Vistra $2 billion secured notes offering
The investment-grade notes are due 2028, 2030 and 2035
American Industrial Partners $1.5 billion acquisition of Global Cellulose Fibers
We are advising American Industrial Partners on the transaction
Guardian Metal Resources $68 million U.S. IPO
We advised Guardian Metal on its U.S. IPO
Comprehensive financing for Honeywell spinoff of Honeywell Aerospace
We advised the banks on the debut investment-grade senior notes offering, cash tender offer and revolving credit facilities
Valero Energy $850 million senior notes offering
We advised the joint book-running managers on the offering
Baker Hughes $6.5 billion senior notes offering
We advised the underwriters on the investment-grade notes offering
Baker Hughes €3 billion senior notes offering
We advised the underwriters on the investment-grade notes offering
Abbott Laboratories $20 billion notes offering
We advised the joint book-running managers on the offering
indie Semiconductor $150 million convertible senior notes offering
We advised the representatives of the initial purchasers on the offering
MiniMed $560 million IPO
The carve-out IPO of Medtronic’s diabetes unit is the second largest medtech IPO ever
Canadian Pacific Railway $1.2 billion notes offering
We advised the joint-bookrunning managers on the investment grade offering
Niagara Mohawk Power $1 billion senior notes offering
We advised the underwriters on the offering